 Ocugen Inc NASDAQ: OCGN shares are trading lower by 22.8 at 2.54 after the company announced the FDA declined to issue an EUA for COVAXIN for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 2 to 18 years of age. Ocugen says the company intends to continue working. 